You are here

Article info

Article menu

Download PDFPDF

Editorial
Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases
Free

Authors

  1. Correspondence to Dr Leonard Calabrese, Department of Rheumatology/Immunology, Cleveland Clinic, 9500 Euclid Drive, Cleveland, OH 44106, USA; calabrl{at}ccf.org
View Full Text

Citation

Calabrese L, Velcheti V
Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases
Annals of the Rheumatic Diseases 2017;76:1-3.

Publication history

  • Received June 21, 2016
  • Revised August 9, 2016
  • Accepted August 10, 2016
  • First published August 26, 2016.
Online issue publication 
November 02, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/